Rianna Rozendaal, M.Sc., the study's lead researcher at the Erasmus Medical Center in Rotterdam said that the results revealed that glucosamine sulfate does not appear to treat hip arthritis and that the difference between glucosamine and placebo group in treating mild to moderate hip arthritis were small.
For two years, the study covered 222 patients with hip arthritis with either 1500 mg of glucosamine or placebo daily. At the beginning of the study, the patient's pain and function levels were acquired and every three months thereafter. Their joints were x-rayed at the start of the trial and after two years.
After the study, it was found that glucosamine does not exhibit relief for pain in hip arthritis and that it shows no significant improvement in the x-rays for people taking glucosamine
The results of the study were published in the Feb. 19 issue of the Annals of Internal Medicine.
